Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Zoetis Inc Cl A (ZTS)

Zoetis Inc Cl A (ZTS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 75,926,512
  • Shares Outstanding, K 474,986
  • Annual Sales, $ 6,675 M
  • Annual Income, $ 1,638 M
  • 60-Month Beta 0.62
  • Price/Sales 11.39
  • Price/Cash Flow 33.28
  • Price/Book 20.15
Trade ZTS with:

Options Overview

Details
  • Implied Volatility 24.38%
  • Historical Volatility 18.49%
  • IV Percentile 15%
  • IV Rank 12.01%
  • IV High 45.88% on 05/04/20
  • IV Low 21.44% on 08/21/20
  • Put/Call Vol Ratio 0.46
  • Today's Volume 1,226
  • Volume Avg (30-Day) 1,062
  • Put/Call OI Ratio 1.15
  • Today's Open Interest 20,204
  • Open Int (30-Day) 16,544

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 15 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/21
See More
  • Average Estimate 1.03
  • Number of Estimates 8
  • High Estimate 1.06
  • Low Estimate 1.00
  • Prior Year 0.95
  • Growth Rate Est. (year over year) +8.42%

Price Performance

See More
Period Period Low Period High Performance
1-Month
151.73 +7.12%
on 03/25/21
163.15 -0.38%
on 04/12/21
+9.96 (+6.53%)
since 03/12/21
3-Month
141.41 +14.94%
on 03/05/21
170.07 -4.43%
on 02/18/21
+0.58 (+0.36%)
since 01/13/21
52-Week
121.50 +33.77%
on 05/14/20
176.64 -7.99%
on 11/05/20
+39.58 (+32.19%)
since 04/13/20

Most Recent Stories

More News
FibroGen (FGEN) DMD Drug Pamrevlumab Gets FDA's Fast Track Tag

The FDA bestows a Fast Track designation to FibroGen's (FGEN) anti-CTGF antibody, pamrevlumab, to treat patients with Duchenne muscular dystrophy. Shares up.

ZTS : 163.81 (+0.80%)
INFI : 2.95 (-1.67%)
FGEN : 18.99 (-4.52%)
CTLT : 107.86 (-1.39%)
Sanofi (SNY) Acquires Tidal to Aid mRNA-Based Research Platform

Sanofi's (SNY) acquisition of Tidal Therapeutics for $160 million is set to aid innovative mRNA-based research platform with applications in oncology, immunology and other diseases.

SNY : 50.19 (-0.12%)
ZTS : 163.81 (+0.80%)
RGEN : 210.65 (+1.75%)
ABBV : 108.11 (-0.13%)
Zoetis to Host Webcast and Conference Call on First Quarter 2021 Financial Results

Zoetis Inc.(NYSE:ZTS) will host a webcast and conference call at 8:30 a.m. (ET) on Thursday, May 6, 2021. Chief Executive Officer Kristin Peck and Executive Vice President and Chief Financial Officer Glenn...

ZTS : 163.81 (+0.80%)
The Zacks Analyst Blog Highlights: Apple, Alibaba Group, AT&T, Intuitive Surgical and Zoetis

The Zacks Analyst Blog Highlights: Apple, Alibaba Group, AT&T, Intuitive Surgical and Zoetis

T : 29.75 (-0.70%)
ISRG : 792.59 (+1.71%)
AAPL : 132.83 (+1.21%)
ZTS : 163.81 (+0.80%)
BABA : 242.70 (-0.54%)
Top Stock Reports for Apple, Alibaba & AT&T

Top Stock Reports for Apple, Alibaba & AT&T

ZTS : 163.81 (+0.80%)
TXN : 191.11 (-0.69%)
T : 29.75 (-0.70%)
ISRG : 792.59 (+1.71%)
BABA : 242.70 (-0.54%)
AAPL : 132.83 (+1.21%)
Pfizer (PFE) Gets Unfavorable Votes from FDA Panel for Tanezumab

Pfizer (PFE) and Eli Lilly receive FDA Joint Advisory Committee's vote results for tanezumab being developed for treating osteoarthritis pain. The committee voted 1 in favor and 19 against tanezumab.

JNJ : 158.84 (-1.73%)
PFE : 37.44 (+1.27%)
LLY : 183.09 (+0.70%)
ZTS : 163.81 (+0.80%)
Novartis (NVS) Posts Positive Data From Prostate Cancer Study

Novartis (NVS) reports positive data from the phase III VISION study evaluating its radioligand therapy, 177Lu-PSMA-617, in patients with advanced prostate cancer.

JNJ : 158.84 (-1.73%)
NVS : 86.90 (-0.50%)
ZTS : 163.81 (+0.80%)
RGEN : 210.65 (+1.75%)
Zoetis (ZTS) Down 7.5% Since Last Earnings Report: Can It Rebound?

Zoetis (ZTS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

ZTS : 163.81 (+0.80%)
Translate (TBIO) Down on Unsatisfactory CF Drug Study Results

Translate Bio (TBIO) announces data from second interim analysis of phase I/II study evaluating MRT5005 in patients with cystic fibrosis. The candidate fails to improve lung function in patients.

SNY : 50.19 (-0.12%)
ZTS : 163.81 (+0.80%)
TBIO : 17.43 (+1.81%)
CTLT : 107.86 (-1.39%)
USNA vs. ZTS: Which Stock Should Value Investors Buy Now?

USNA vs. ZTS: Which Stock Is the Better Value Option?

USNA : 100.60 (-0.03%)
ZTS : 163.81 (+0.80%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Business Summary

Zoetis discovers, develops, manufactures and markets veterinary vaccines and medicines, complemented by diagnostic products and genetic tests and supported by a range of services.

See More

Key Turning Points

3rd Resistance Point 168.90
2nd Resistance Point 166.02
1st Resistance Point 164.27
Last Price 163.81
1st Support Level 159.64
2nd Support Level 156.76
3rd Support Level 155.01

See More

52-Week High 176.64
Last Price 163.81
Fibonacci 61.8% 155.58
Fibonacci 50% 149.07
Fibonacci 38.2% 142.56
52-Week Low 121.50

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar